Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002538 · ClinicalTrials.gov registry record · Phase 2
Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers
A Phase 2 study of Ovarian Cancer and Fallopian Tube Cancer, sponsored by Gynecologic Oncology Group.
- Completed
- Registry status
- Phase 2
- Development phase
- 11
- Study locations
NCT00002538: Completed Phase 2 study of Ovarian Cancer and Fallopian Tube Cancer, sponsored by Gynecologic Oncology Group.
NCT00002538 is a Phase 2 study of Ovarian Cancer and Fallopian Tube Cancer that has completed, run by Gynecologic Oncology Group. The trial reports 11 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002538, a Phase 2 study of Ovarian Cancer and Fallopian Tube Cancer, has completed, sponsored by Gynecologic Oncology Group.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 11
- Study locations
Study Summary
RATIONALE: Laparoscopic staging may help doctors plan more effective treatment for ovarian, primary fallopian tube, and primary abdominal cancers. PURPOSE: Phase II trial to study the effectiveness of laparoscopic staging in patients with ovarian, primary fallopian tube, or primary abdominal cancers who have not undergone complete staging.
Conditions Studied
Interventions
- PROCEDURE laparoscopic surgery
Study Locations (11)
California
- USC/Norris Comprehensive Cancer Center - Los Angeles
- Jonsson Comprehensive Cancer Center, UCLA - Los Angeles
- Women's Cancer Center - Palo Alto
District of Columbia
- Vincent T. Lombardi Cancer Research Center, Georgetown University - Washington D.C.
- Walter Reed Army Medical Center - Washington D.C.
North Carolina
- Duke Comprehensive Cancer Center - Durham
- Comprehensive Cancer Center of Wake Forest University Baptist Medical Center - Winston-Salem
Illinois
- Rush-Presbyterian-St. Luke's Medical Center - Chicago
Minnesota
- University of Minnesota Cancer Center - Minneapolis
Oklahoma
- University of Oklahoma College of Medicine - Oklahoma City
Pennsylvania
- Abington Memorial Hospital - Abington
Trial Details
| Field | Value |
|---|---|
| Start Date | 1993-09 |
| Phase | Phase 2 |
What the finished NCT00002538 record still lists
NCT00002538 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 3 conditions, with Ovarian Cancer appearing as the primary indexed condition, and to 1 intervention - of which laparoscopic surgery is the first listed.
NCT00002538 lists 11 locations in 7 states (California, District of Columbia, North Carolina).
Frequently Asked Questions
What is clinical trial NCT00002538 about?
NCT00002538 is a clinical study titled "Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers". RATIONALE: Laparoscopic staging may help doctors plan more effective treatment for ovarian, primary fallopian tube, and primary abdominal cancers. PURPOSE: Phase II trial to study the effectiveness of laparoscopic staging in patients with ovarian, primary fallopian tube, or primary abdominal cancer...
What is the current status of trial NCT00002538?
This trial is currently completed. It is a Phase 2 study. The study started on 1993-09.
What conditions does trial NCT00002538 study?
This clinical trial studies the following conditions: Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cavity Cancer.
What interventions are being tested in trial NCT00002538?
The interventions under investigation include: laparoscopic surgery (PROCEDURE).
Who is sponsoring clinical trial NCT00002538?
This trial is sponsored by Gynecologic Oncology Group, which has 154 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00002538 being conducted?
This trial has 11 study locations across California, District of Columbia, Illinois, Minnesota, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ovarian Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
RECRUITING · Phase 2
-
A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery
RECRUITING · Phase 2
-
Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer
RECRUITING · Phase 2
-
Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer
RECRUITING · Phase 2
-
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
RECRUITING · Phase 2
-
Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Cancer (HI-MOC Study)
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia